Table 2.

Clinical and angiographic characteristics according to the median neuropeptide Y (NPY) levels pre-primary percutaneous intervention (PPCI)

	NPY pre-PPCI <median (n=32)	NPY pre-PPCI >median (n=32)	p Value
Age	61.4±12.2	63.81±1.3	0.42
Males	27/32 (84%)	20/32 (63%)	0.05
Cardiovascular risk factors
Hypertension	11/32 (34%)	18/32 (56%)	0.08
Hyperlipidaemia	12/32 (38%)	18/32 (56%)	0.13
Diabetes mellitus	1/32 (3%)	8/32 (25%)	0.01
Smoking	9/32 (28%)	11/32 (34%)	0.29
BP and heart rate at presentation
Systolic BP (mm Hg)	128±26	142±19	0.02
Diastolic BP (mm Hg)	80±15	82±16	0.65
Heart rate (/min)	72±15	85±22	0.01
Pain-to-balloon time (min)	219±205	211±143	0.84
TIMI 0 (at presentation)	8/32 (25%)	11/32 (34%)	0.41
TIMI 3 (at end of PPCI)	30/32 (94%)	25/32 (78%)	0.07
Angiographic reflow (TIMI 3 and MBG ≥2)	27/32 (84%)	21/32 (66%)	0.08
Anterior infarction	16/32 (50%)	16/32 (50%)	1.00
Log AUC troponin I	1.86±0.81	2.18±0.62	0.08

AUC, area under the curve; BP, blood pressure; MBG, myocardial blush grade; TIMI, thrombolysis in myocardial infarction.